You are here
Dendritic Cell Subset for Enhanced Cancer Vaccine
Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43CA105686-01A1
Agency Tracking Number: CA105686
Amount:
$109,586.00
Phase:
Phase I
Program:
SBIR
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Timeline
Solicitation Year:
2004
Award Year:
2004
Award Start Date (Proposal Award Date):
N/A
Award End Date (Contract End Date):
N/A
Small Business Information
AASTROM BIOSCIENCES, INC.
BOX 376
ANN ARBOR, MI
48105
United States
DUNS:
N/A
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: DOUGLAS Smith
Phone: (734) 930-5789
Email: DSMITH@AASTROM.COM
Phone: (734) 930-5789
Email: DSMITH@AASTROM.COM
Business Contact
Name: ALAN WRIGHT
Phone: (734) 930-5555
Email: AWRIGHT@AASTROM.COM
Phone: (734) 930-5555
Email: AWRIGHT@AASTROM.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Tumor antigen primed dendritic cells (DCs) are under widespread clinical evaluation for immunotherapy of multiple forms of cancer. Emerging evidence suggests that DCs are fundamental regulators of the immune response
* Information listed above is at the time of submission. *
